沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

圣诞节后第一个工作日休市 12-24 12:08:24

6.410

+0.190

+3.05%

最高6.450	最低6.210	成交量74.57万
今开6.240	昨收6.220	日振幅3.86%
总市值43.01亿	流通市值43.01亿	总股本6.71亿
成交额471.99万	换手率0.11%	流通股本6.71亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":6.41,"timestamp":1766549304011,"preClose":6.22,"halted":0,"volume":745736,"delay":0,"floatShares":671000000,"shares":671000000,"eps":-0.3754516990417272,"marketStatus":"圣诞节后第一个工作日休市","change":0.19,"latestTime":"12-24 12:08:24","open":6.24,"high":6.45,"low":6.21,"amount":4719851,"amplitude":0.038585,"askPrice":6.41,"askSize":15000,"bidPrice":6.35,"bidSize":218000,"shortable":3,"etf":0,"ttmEps":-0.3769116552394128,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":6.22,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":1.3284365993408753,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2594262364","title":"九强生物(300406.SZ)：两款产品取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2594262364","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594262364?lang=zh_cn&edition=full","pubTime":"2025-12-26 15:54","pubTimestamp":1766735660,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司及全资子公司北京美创新跃医疗器械有限公司(以下简称“美创新跃”)于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，涉及产品：“丙氨酸氨基转移酶测定试剂盒(丙氨酸底物法)”、“D-二聚体测定试剂盒(胶乳免疫比浊法)”。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386014.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","300406","BK0012","BK1100","BK1222","159883","BK1583","BK0046","BK0077","BK1574","09997","09996","BK0028"],"gpt_icon":0},{"id":"2594826411","title":"普门科技(688389.SH)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2594826411","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594826411?lang=zh_cn&edition=full","pubTime":"2025-12-26 15:37","pubTimestamp":1766734630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，普门科技(688389.SH)发布公告，公司于近期收到了1个广东省药品监督管理局颁发的《中华人民共和国医疗器械注册证(体外诊断试剂)》，产品名称：叶酸测定试剂盒(电化学发光法)。本次取得注册证的叶酸测定试剂盒(电化学发光法)，为公司新一代产品，采用夹心化学发光免疫分析法，进一步提高了试剂的灵敏度、精密度等性能，将有助于提升公司在贫血检测领域的市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","09997","BK0251","09996","BK1583","688389","BK1574","159883","BK1100"],"gpt_icon":0},{"id":"2594263071","title":"建发致新：目前医疗器械SPD管理业务主要竞争对手有国药集团、上海医药、华润医药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2594263071","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594263071?lang=zh_cn&edition=full","pubTime":"2025-12-26 11:36","pubTimestamp":1766720166,"startTime":"0","endTime":"0","summary":"证券之星消息，建发致新(301584)12月25日在投资者关系平台上答复投资者关心的问题。投资者提问：公司spd 系统，目前竞争对手有哪几家，份额占比多少建发致新回复：你好，尊敬的投资者。目前医疗器械SPD管理业务行业主要竞争对手有国药集团、上海医药、华润医药等医药商业企业，除此之外存在部分SPD专业管理公司如国医科技、德荣医疗、塞力医疗等。市场份额方面，根据部分市场报告显示，国药集团目前居于行业主导地位，其余公司呈现分散竞争的格局。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600012621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03320","BK0196","BK0012","BK0099","301584","BK1100","BK0187","BK1222","09996","09997","159883","BK0184","BK1583","BK0183","BK1197","BK1570","BK0020","BK0250","BK0097","BK1191","BK0028","601607","BK0175","BK0188","BK1574","02607","BK0209"],"gpt_icon":0},{"id":"2594237041","title":"戴维医疗（300314）披露部分医疗器械产品完成延续注册，12月25日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594237041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594237041?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:53","pubTimestamp":1766674394,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，戴维医疗报收于12.92元，较前一交易日上涨0.16%，最新总市值为37.21亿元。该股当日开盘12.88元，最高12.95元，最低12.84元，成交额达2315.5万元，换手率为1.25%。公司近日发布公告称，宁波戴维医疗器械股份有限公司取得浙江省药品监督管理局颁发的《医疗器械注册证》，产品医用空气压缩机完成延续注册，注册证编号为浙械注准20212080048，有效期至2031年2月2日，产品类别为Ⅱ类，适用于为呼吸机或类似呼吸通气系统提供压缩空气源。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0251","159883","09997","BK1222","BK0042","BK1574","BK0046","300314","BK1583","BK1100","09996"],"gpt_icon":0},{"id":"2594236398","title":"新华医疗（600587）披露公司产品获得三类和二类医疗器械注册证，12月25日股价上涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594236398","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594236398?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:47","pubTimestamp":1766656043,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，新华医疗报收于14.7元，较前一交易日上涨0.48%，最新总市值为89.18亿元。该股当日开盘14.65元，最高14.73元，最低14.63元，成交额达6329.55万元，换手率为0.71%。近日，新华医疗发布公告称，公司及全资子公司山东新华血液技术有限公司获得国家药品监督管理局和山东省药品监督管理局颁发的多项医疗器械注册证。注册证有效期均为五年。上述产品注册证的取得有助于提升公司在血液透析和体外诊断领域的市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500026827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","159883","BK1574","BK0188","BK0251","09996","BK1583","BK1222","09997","BK1100","600587"],"gpt_icon":0},{"id":"2594380882","title":"万泰生物(603392.SH)：HIV抗体口腔黏膜渗出液自我检测试剂取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2594380882","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594380882?lang=zh_cn&edition=full","pubTime":"2025-12-25 16:07","pubTimestamp":1766650058,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万泰生物 发布公告，近日，公司自主研发的人类免疫缺陷病毒抗体口腔黏膜渗出液检测试剂盒取得国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》。标志着公司在艾滋病自我检测领域的技术领先地位和创新能力再次得到国家权威认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","09633","603392","BK1222","159883","BK1100","LU1981816686.USD","BK1200","09996","BK1574","BK0239","09997","BK1589"],"gpt_icon":0},{"id":"2594675281","title":"建发致新：布局创新医疗器械分销业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2594675281","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594675281?lang=zh_cn&edition=full","pubTime":"2025-12-25 11:33","pubTimestamp":1766633614,"startTime":"0","endTime":"0","summary":"公司在过去四、五年期间，利用自身全国性医疗器械流通平台的定位，一方面积极布局产品多元降低单一产品的阶段性收入波动；另一方面，利用全国网络渠道优势积极布局创新医疗器械的分销业务；此外，顺应DRGS政策实施下医院耗材精益化管理需求，布局SPD管理业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500013576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1574","BK0250","BK1583","09996","BK1222","09997","BK1100","301584"],"gpt_icon":0},{"id":"2594816222","title":"《医疗器械出口销售证明管理规定》发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2594816222","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594816222?lang=zh_cn&edition=full","pubTime":"2025-12-25 11:30","pubTimestamp":1766633441,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，12月25日，国家药监局发布《医疗器械出口销售证明管理规定》(以下简称《规定》)。《规定》将于2026年5月1日起施行。《规定》是国家药监局贯彻落实《国务院办公厅关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见》(国办发〔2024〕53号)，大力支持医疗器械出口，优化药品监督管理部门出具医疗器械出口销售证明的服务性事项办理的重要举措。《规定》的发布，将为我国医疗器械产品出口提供更大范围的支持和更加便利的服务，助力我国医疗器械产品加快“出海”，更好走向世界，助力全球公众健康。本文编选自国家药监局，智通财经编辑：陈雯芳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1100","BK1574","BK1583","159883","BK1222","09996"],"gpt_icon":0},{"id":"2593447932","title":"科华生物最新公告：控股子公司产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447932","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447932?lang=zh_cn&edition=full","pubTime":"2025-12-24 18:50","pubTimestamp":1766573440,"startTime":"0","endTime":"0","summary":"科华生物(002022.SZ)公告称，近日，公司控股子公司西安天隆科技有限公司收到国家药品监督管理局颁发的医疗器械注册证。该产品为人类ALDH2基因多态性检测试剂盒（荧光PCR法），注册证编号为国械注准20253402670，有效期至2030年12月22日。该试剂盒用于体外定性检测人全血样本基因组DNA中ALDH2基因c.1510G>A位点的多态性。新产品的取得丰富了公司产品线，对公司业务发展具有正面影响，但对未来营业收入的影响尚无法预测。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400031354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK0028","BK1100","BK1583","159883","BK0188","09997","BK1222","BK1574","BK0046","BK0239","002022"],"gpt_icon":0},{"id":"2593475762","title":"安杰思(688581.SH)子公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593475762","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593475762?lang=zh_cn&edition=full","pubTime":"2025-12-24 18:01","pubTimestamp":1766570500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安杰思(688581.SH)发布公告，近日，公司的控股子公司杭安医学科技(杭州)有限公司(简称“杭安医学”)获得浙江省药品监督管理局颁发的医疗器械注册证。产品名称分别为：电子内窥镜图像处理器、上消化道电子内窥镜、下消化道电子内窥镜。上述医疗器械注册证的取得，进一步丰富了公司在内镜领域诊疗领域的产品线，不断满足多元化的临床需求，有助于提高公司的市场综合竞争力，对公司的可持续发展将产生积极的影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","159883","09996","BK1222","BK1583","09997","688581","BK1574","BK0251"],"gpt_icon":0},{"id":"2593756624","title":"三诺生物（300298）披露取得医疗器械注册证，12月24日股价上涨0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593756624","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593756624?lang=zh_cn&edition=full","pubTime":"2025-12-24 17:52","pubTimestamp":1766569946,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，三诺生物报收于17.14元，较前一交易日上涨0.71%，最新总市值为96.03亿元。该股当日开盘17.02元，最高17.16元，最低16.96元，成交额达7835.09万元，换手率为1.02%。公司近日发布公告称，三诺生物传感股份有限公司近日获得湖南省药品监督管理局颁发的四项医疗器械注册证。其中，血糖尿酸血酮分析仪为新获批注册证，其余三项为延续注册。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400029162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK0251","BK0114","BK1583","BK1100","BK0102","300298","BK1574","BK1222","159883","09996"],"gpt_icon":0},{"id":"2593427518","title":"九强生物(300406.SZ)取得三项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2593427518","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593427518?lang=zh_cn&edition=full","pubTime":"2025-12-24 15:48","pubTimestamp":1766562483,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，涉及产品：“D-二聚体校准品”、“降钙素测定试剂盒(磁微粒化学发光免疫分析法)”、“霉酚酸测定试剂盒(IMPDHⅡ法)”。上述产品医疗器械注册证的取得，丰富了公司在体外诊断生化、化学发光及血凝细分领域产品线的品种，有利于进一步提升公司的核心竞争力和市场拓展能力，对公司未来的经营将产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","159883","300406","BK0028","09997","09996","BK0046","BK0239","BK0012","BK1100","BK1574","BK1222","BK0077"],"gpt_icon":0},{"id":"2593441524","title":"亚辉龙（688575）披露取得医疗器械注册证，12月23日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593441524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593441524?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:25","pubTimestamp":1766499909,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，亚辉龙报收于14.26元，较前一交易日下跌0.77%，最新总市值为81.48亿元。该股当日开盘14.38元，最高14.44元，最低14.21元，成交额达4380.86万元，换手率为0.54%。公司近日发布公告称，深圳市亚辉龙生物科技股份有限公司及全资子公司湖南亚辉龙生物科技有限公司近日分别收到广东省药品监督管理局和湖南省药品监督管理局签发的医疗器械注册证。截至目前，公司已取得257个化学发光试剂国内注册证，其中180项为全自动化学发光试剂。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300040409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","BK1222","BK0239","688575","159883","09997","09996","BK1100"],"gpt_icon":0},{"id":"2593413090","title":"复星医药：公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413090","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593413090?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:08","pubTimestamp":1766498900,"startTime":"0","endTime":"0","summary":"证券日报网讯12月23日，复星医药在互动平台回答投资者提问时表示，公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块，其中药品、器械及诊断产品的主要市场包括中国、美国、欧洲及新兴市场在内的多个国家和地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599787764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0187","BK1100","BK1222","BK0239","BK0175","BK1583","XBI","159760","BK1574","BK0196","XLV","LABU","BK4581","BK1593","BK4588","01477","BK0188","BK0060","09997","BK4585","BK1191","BK0183","BK1515","BK0096","BK0028","09996","02196","159883","BK0012","600196"],"gpt_icon":0},{"id":"2593499851","title":"亚辉龙(688575.SH)及子公司取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593499851","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593499851?lang=zh_cn&edition=full","pubTime":"2025-12-23 18:05","pubTimestamp":1766484305,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚辉龙(688575.SH)发布公告，公司及全资子公司湖南亚辉龙生物科技有限公司于近日分别收到了由广东省药品监督管理局和湖南省药品监督管理局签发的医疗器械注册证，产品名称：涎液化糖链抗原(KL-6)测定试剂盒(化学发光法)、抗黑色素瘤分化相关基因5IgG抗体测定试剂盒(化学发光法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK0239","BK1100","159883","09997","09996","BK1222","688575","BK1583"],"gpt_icon":0},{"id":"2593447039","title":"每日卖空追踪 | 沛嘉医疗-B 12月23日卖空量成交8.1万股，卖空比例为4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447039?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:30","pubTimestamp":1766478642,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B北京时间12月23日，涨3.15%，卖空量成交8.1万股，较上一交易日增加268.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163626a6c5209c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163626a6c5209c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1583","BK1574","BK1100"],"gpt_icon":0},{"id":"2593640394","title":"吉林通报不合格医疗器械 大安爱尔眼科眼部热敷贴登榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2593640394","media":"中金财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593640394?lang=zh_cn&edition=full","pubTime":"2025-12-23 14:57","pubTimestamp":1766473024,"startTime":"0","endTime":"0","summary":"中国经济网北京12月23日讯 吉林省药品监督管理局网站近期发布吉林省医疗器械质量公告 。为加强医疗器械质量监督管理，保障医疗器械产品使用安全有效，吉林省药品监督管理局在全省范围内组织开展质量抽查检验，现将本期不合格产品信息予以公告。药品监督管理部门已要求相关单位采取风险防控措施，对不合格产品依据相关法律法规进行查处。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/23/20251223711027.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/23/20251223711027.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251223/31884513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0236","BK1100","BK0200","LU0979878070.USD","BK0028","BK1222","BK0113","09997","BK1583","BK0096","BK0188","BK0077","LU1242518931.SGD","BK0114","09996","159883","LU1242518857.USD","300015","LU1146622755.USD","LU1820825898.SGD","BK1574","BK0012","BK0196"],"gpt_icon":0},{"id":"2593447209","title":"医疗器械行业行业研究：第六批医用耗材国采文件发布，规则细节及报量符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447209","media":"国金证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447209?lang=zh_cn&edition=full","pubTime":"2025-12-23 12:06","pubTimestamp":1766462777,"startTime":"0","endTime":"0","summary":"事件2025 年 12 月 22 日，国家组织高值医用耗材联合采购办公室发布《国家组织药物涂层球囊类、泌尿介入类医用耗材集中带量采购文件》的公告，企业申报材料递交及信息公开将在 2026 年 1 月 13 日进行。规则一中选企业同时须满足： 竞价比价价格<同竞价单元“锚点价格” 1.5 倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223120626a6c42f22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223120626a6c42f22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","06669","09997","09996","BK1222","BK1587","BK1583"],"gpt_icon":0},{"id":"2593211485","title":"东方海洋（002086）披露全资子公司取得医疗器械注册证，12月22日股价下跌0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593211485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593211485?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:53","pubTimestamp":1766397185,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，东方海洋报收于2.4元，较前一交易日下跌0.41%，最新总市值为47.01亿元。该股当日开盘2.42元，最高2.42元，最低2.4元，成交额达7200.52万元，换手率为1.89%。公司近日发布公告称，其全资子公司艾维可生物科技有限公司自主研发的降钙素原测定试剂盒已取得山东省药品监督管理局颁发的医疗器械注册证，注册证编号为鲁械注准20252400747，有效期至2030年12月10日。该产品适用于体外定量检测人血清、血浆、全血中的降钙素原含量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200022621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","09997","159883","BK1100","BK0046","BK1574","BK0092","BK1222","09996","BK0213","002086"],"gpt_icon":0},{"id":"2593107719","title":"东方海洋(002086.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593107719","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593107719?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391307,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方海洋(002086.SZ)发布公告，公司全资子公司艾维可生物科技有限公司自主研发的降钙素原(PCT)测定试剂盒(荧光免疫层析法)于近日取得了山东省药品监督管理局的注册批准，获得医疗器械注册证。上述产品获准上市，进一步丰富了艾维可生物科技有限公司在临床检测领域的产品线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0213","BK0092","BK1574","BK1583","BK0046","BK1222","159883","002086","09997","09996","BK1100"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":0.1187},{"period":"1month","weight":0.2049},{"period":"3month","weight":0.0175},{"period":"6month","weight":0.0031},{"period":"1year","weight":0.6106},{"period":"ytd","weight":0.6106}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.088172},{"month":2,"riseRate":0.6,"avgChangeRate":0.039503},{"month":3,"riseRate":0.4,"avgChangeRate":-0.110838},{"month":4,"riseRate":0.75,"avgChangeRate":0.044776},{"month":5,"riseRate":0.75,"avgChangeRate":-0.061692},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07739},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.096159}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}